China's Top 10 Achievements in Hematology in 2022

Overview

Journal Blood Sci

Date 2023 May 25

PMID 37228775

Authors

Xiaochen Wang

Affiliations

Soon will be listed here.

Citing Articles

China's top 10 achievements in hematology in 2023.

Liu S, Chen B Blood Sci. 2024; 6(3):e00195.

PMID: 38854482 PMC: 11161293. DOI: 10.1097/BS9.0000000000000195.

References

Yuan F, Cai J, Wu J, Tang Y, Zhao K, Liang F . Z-DNA binding protein 1 promotes heatstroke-induced cell death. Science. 2022; 376(6593):609-615. DOI: 10.1126/science.abg5251. View

Li C, Wu B, Li Y, Liu Y, Wang J, Xie J . Loss of sphingosine kinase 2 promotes the expansion of hematopoietic stem cells by improving their metabolic fitness. Blood. 2022; 140(15):1686-1701. DOI: 10.1182/blood.2022016112. View

Xue F, Li H, Wu X, Liu W, Zhang F, Tang D . Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial. Lancet Haematol. 2022; 9(7):e504-e513. DOI: 10.1016/S2352-3026(22)00113-2. View

Zhang H, Fan Z, Huang F, Han L, Xu Y, Xu N . Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial. J Clin Oncol. 2022; 41(2):343-353. PMC: 9839269. DOI: 10.1200/JCO.22.00767. View

Harousseau J . CAR-T cell therapy in myeloma: hopes and hurdles. Blood Sci. 2023; 5(2):136-137. PMC: 10205213. DOI: 10.1097/BS9.0000000000000148. View

Xu C, He J, Wang H, Zhang Y, Wu J, Zhao L . Single-cell transcriptomic analysis identifies an immune-prone population in erythroid precursors during human ontogenesis. Nat Immunol. 2022; 23(7):1109-1120. DOI: 10.1038/s41590-022-01245-8. View

Li C, Wu B, Li Y, Chen J, Ye Z, Tian X . Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2α axis. Cell Stem Cell. 2022; 29(7):1119-1134.e7. DOI: 10.1016/j.stem.2022.06.004. View

Qi Y, Zhao M, Hu Y, Wang Y, Li P, Cao J . Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL. Blood. 2022; 139(23):3376-3386. PMC: 11022988. DOI: 10.1182/blood.2021013733. View

Zheng Z, He H, Tang X, Zhang H, Gou F, Yang H . Uncovering the emergence of HSCs in the human fetal bone marrow by single-cell RNA-seq analysis. Cell Stem Cell. 2022; 29(11):1562-1579.e7. DOI: 10.1016/j.stem.2022.10.005. View

10.

Zhang Y, Wang S, Zhang J, Liu C, Li X, Guo W . Elucidating minimal residual disease of paediatric B-cell acute lymphoblastic leukaemia by single-cell analysis. Nat Cell Biol. 2022; 24(2):242-252. DOI: 10.1038/s41556-021-00814-7. View

11.

Wang J, Yang D . Big stride in gene therapy for hemophilia B in China. Blood Sci. 2023; 5(2):138-139. PMC: 10205292. DOI: 10.1097/BS9.0000000000000150. View

12.

Xue F, Wang P, Yuan Z, Shi C, Fang Y, Liu W . Total Knee Arthroplasty after Gene Therapy for Hemophilia B. N Engl J Med. 2022; 387(17):1622-1624. PMC: 9933182. DOI: 10.1056/NEJMc2211173. View

13.

Wang Y, Cao J, Gu W, Shi M, Lan J, Yan Z . Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma. J Clin Oncol. 2022; 40(20):2246-2256. DOI: 10.1200/JCO.21.01676. View

14.

Zhang J, Hu Y, Yang J, Li W, Zhang M, Wang Q . Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL. Nature. 2022; 609(7926):369-374. PMC: 9452296. DOI: 10.1038/s41586-022-05140-y. View

15.

Mi J, Zhao W, Jing H, Fu W, Hu J, Chen L . Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1). J Clin Oncol. 2022; 41(6):1275-1284. DOI: 10.1200/JCO.22.00690. View